Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
27.32
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-5.35 Insider Own2.59% Shs Outstand147.98M Perf Week2.78%
Market Cap4.06B Forward P/E- EPS next Y-3.95 Insider Trans-7.26% Shs Float144.65M Perf Month-6.53%
Income-749.57M PEG- EPS next Q-1.24 Inst Own101.39% Short Float6.11% Perf Quarter-11.93%
Sales305.21M P/S13.29 EPS this Y12.58% Inst Trans-4.49% Short Ratio5.41 Perf Half Y6.01%
Book/sh-2.24 P/B- EPS next Y15.32% ROA-50.20% Short Interest8.84M Perf Year58.47%
Cash/sh5.26 P/C5.20 EPS next 5Y- ROE-1453.41% 52W Range16.25 - 32.00 Perf YTD-11.84%
Dividend Est.- P/FCF- EPS past 5Y-4.82% ROI-73.74% 52W High-14.63% Beta0.92
Dividend TTM- Quick Ratio3.75 Sales past 5Y275.45% Gross Margin76.86% 52W Low68.07% ATR (14)0.92
Dividend Ex-Date- Current Ratio4.12 EPS Y/Y TTM-37.57% Oper. Margin-223.10% RSI (14)50.51 Volatility2.51% 3.30%
Employees912 Debt/Eq- Sales Y/Y TTM24.39% Profit Margin-245.59% Recom1.06 Target Price43.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-6.48% Payout- Rel Volume0.00 Prev Close27.32
Sales Surprise2.22% EPS Surprise-11.01% Sales Q/Q41.13% EarningsFeb 22 BMO Avg Volume1.63M Price27.32
SMA200.69% SMA50-1.75% SMA2008.51% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Outperform $42
Dec-08-23Initiated Wells Fargo Overweight $55
Nov-20-23Resumed JP Morgan Overweight $36
Jul-26-23Initiated Guggenheim Buy $50
Dec-09-22Initiated Mizuho Buy $28
Dec-07-22Initiated Barclays Overweight $37
Nov-18-22Initiated BofA Securities Buy $39
Apr-27-22Initiated Goldman Buy $56
Dec-06-21Initiated JP Morgan Overweight $45
Oct-19-21Resumed Morgan Stanley Overweight $56 → $52
Mar-27-24 04:05PM
Mar-05-24 08:00AM
Feb-29-24 08:00AM
Feb-28-24 04:05PM
Feb-23-24 12:23PM
10:35PM Loading…
Feb-22-24 10:35PM
08:10AM
07:28AM
07:00AM
Feb-15-24 10:00AM
Feb-13-24 01:35PM
Feb-08-24 08:00AM
Feb-02-24 04:05PM
Jan-13-24 05:13PM
Jan-12-24 05:02PM
02:32AM Loading…
Jan-06-24 02:32AM
Jan-05-24 08:00AM
Jan-04-24 08:00AM
Jan-02-24 08:00AM
Dec-23-23 11:01AM
Dec-05-23 01:34PM
08:00AM
Nov-29-23 08:00AM
Nov-14-23 03:56PM
Nov-08-23 08:00AM
Nov-03-23 08:00AM
Nov-02-23 08:00AM
Oct-30-23 01:53AM
Oct-28-23 03:19PM
Oct-26-23 04:05PM
09:32AM Loading…
09:32AM
08:50AM
07:41AM
07:30AM
Oct-24-23 10:00AM
08:00AM
Oct-19-23 10:02AM
Oct-12-23 08:00AM
Oct-06-23 08:00AM
Sep-26-23 08:00AM
Sep-08-23 02:09PM
08:00AM
Sep-06-23 08:00AM
07:46AM
Sep-05-23 07:32PM
04:10PM
12:18PM
11:52AM
07:00AM
Aug-04-23 08:00AM
Aug-03-23 09:05AM
07:55AM
07:30AM
Jul-20-23 08:00AM
Jul-07-23 08:00AM
Jun-30-23 06:14AM
Jun-07-23 08:00AM
Jun-06-23 08:00AM
May-22-23 04:05PM
May-08-23 07:30AM
May-05-23 08:00AM
May-04-23 08:55AM
07:50AM
07:30AM
May-02-23 10:01AM
Apr-27-23 10:03AM
Apr-24-23 08:00AM
Apr-20-23 08:00AM
Apr-18-23 06:34AM
Apr-06-23 08:00AM
Mar-31-23 08:00AM
Mar-24-23 04:22PM
Mar-23-23 06:51AM
Mar-21-23 05:10PM
Mar-03-23 08:00AM
Mar-01-23 08:00AM
Feb-24-23 05:42AM
Feb-23-23 09:15AM
07:30AM
Feb-19-23 07:49AM
Feb-16-23 10:01AM
Feb-09-23 10:01AM
08:00AM
Feb-07-23 08:00AM
Feb-03-23 08:00AM
Jan-26-23 10:45AM
Jan-24-23 09:55AM
Jan-20-23 08:00AM
Jan-19-23 05:48AM
Jan-06-23 08:00AM
Jan-03-23 08:00AM
Dec-06-22 08:00AM
Nov-30-22 08:00AM
Nov-04-22 08:00AM
Nov-03-22 08:26PM
Nov-01-22 08:00AM
Oct-27-22 04:05PM
08:45AM
07:30AM
Oct-25-22 10:01AM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lewis WilliamChair and CEOFeb 28 '24Option Exercise12.5850,000629,00050,500Feb 29 04:08 PM
Adsett RogerChief Operating OfficerJan 12 '24Sale28.635,251150,336148,559Jan 12 04:05 PM
Flammer Martina M.D.Chief Medical OfficerJan 12 '24Sale28.634,667133,616106,898Jan 12 04:06 PM
Adsett RogerChief Operating OfficerJan 10 '24Sale28.903,536102,190153,810Jan 11 04:06 PM
Flammer Martina M.D.Chief Medical OfficerJan 10 '24Sale28.901,24535,980111,565Jan 11 04:08 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 09 '24Option Exercise20.4950310,306105,652Jan 11 04:10 PM
Lewis WilliamChair and CEOJan 09 '24Sale28.729,887283,955363,651Jan 10 04:15 PM
Flammer Martina M.D.Chief Medical OfficerJan 09 '24Sale29.014,715136,782112,810Jan 11 04:08 PM
Bonstein SaraChief Financial OfficerJan 09 '24Sale29.184,497131,222114,051Jan 11 04:07 PM
Adsett RogerChief Operating OfficerJan 09 '24Sale29.253,837112,232157,346Jan 11 04:06 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 09 '24Sale28.853,668105,831101,984Jan 11 04:10 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 09 '24Sale28.762,37368,24786,364Jan 11 04:11 PM
Wise John DraytonChief Commercial OfficerJan 09 '24Sale28.781,86153,560113,829Jan 11 04:13 PM
Lewis WilliamChair and CEOJan 08 '24Option Exercise20.4945,120924,509398,489Jan 10 04:15 PM
Lewis WilliamChair and CEOJan 08 '24Sale29.4545,1201,328,973373,538Jan 10 04:15 PM
Lewis WilliamChair and CEOJan 05 '24Sale29.266,979204,195373,538Jan 05 05:29 PM
Adsett RogerChief Operating OfficerJan 05 '24Sale29.213,04288,864161,183Jan 05 05:26 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 05 '24Sale29.281,45742,661105,149Jan 05 05:32 PM
Flammer Martina M.D.Chief Medical OfficerJan 05 '24Sale29.201,38640,478117,525Jan 05 05:29 PM
Wise John DraytonChief Commercial OfficerJan 05 '24Sale29.321,16734,216115,690Jan 05 05:33 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 05 '24Sale29.3062718,37488,737Jan 05 05:32 PM
Wise John DraytonChief Commercial OfficerJan 03 '24Option Exercise19.1120,071383,557124,055Jan 05 05:33 PM
Wise John DraytonChief Commercial OfficerJan 03 '24Sale29.1920,071585,872103,984Jan 05 05:33 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerDec 28 '23Option Exercise20.4922,288456,681116,837Jan 02 04:04 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerDec 28 '23Sale32.0022,288713,21694,549Jan 02 04:04 PM
Flammer Martina M.D.Chief Medical OfficerDec 22 '23Option Exercise23.6628,310669,815134,348Dec 22 04:04 PM
Flammer Martina M.D.Chief Medical OfficerDec 22 '23Sale30.0028,310849,300106,038Dec 22 04:04 PM
Bonstein SaraChief Financial OfficerDec 22 '23Sale30.0013,199395,970105,241Dec 22 04:03 PM
Lewis WilliamChair and CEOOct 27 '23Option Exercise14.24112,5001,602,000289,274Oct 31 04:04 PM
Lewis WilliamChair and CEOOct 27 '23Sale24.08112,0002,696,4490Oct 31 04:04 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJul 11 '23Sale20.1874014,93377,142Jul 13 04:01 PM
Adsett RogerChief Operating OfficerJun 13 '23Sale19.328,981173,513151,352Jun 15 04:05 PM
Flammer Martina M.D.Chief Medical OfficerJun 13 '23Sale19.278,868170,886106,038Jun 15 04:06 PM
Wise John DraytonChief Commercial OfficerMay 25 '23Sale18.953,36663,786102,681May 26 04:05 PM
Lewis WilliamChair and CEOMay 17 '23Sale18.127,099128,634341,345May 17 04:11 PM
Adsett RogerChief Operating OfficerMay 17 '23Sale18.122,44844,358160,333May 17 04:07 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 17 '23Sale18.161,97235,81293,525May 17 04:13 PM
Wise John DraytonChief Commercial OfficerMay 17 '23Sale18.171,91334,759106,047May 17 04:16 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 17 '23Sale18.181,26322,96177,082May 17 04:14 PM
Lewis WilliamChair and CEOMay 16 '23Sale18.413,71468,375348,444May 17 04:11 PM
Flammer Martina M.D.Chief Medical OfficerMay 16 '23Sale18.431,71831,663114,906May 17 04:10 PM
Bonstein SaraChief Financial OfficerMay 16 '23Sale18.471,61029,737117,619May 17 04:09 PM
Adsett RogerChief Operating OfficerMay 16 '23Sale18.391,52127,971162,781May 17 04:07 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 16 '23Sale18.451,21722,45495,497May 17 04:13 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 16 '23Sale18.434758,75478,345May 17 04:14 PM
Wise John DraytonChief Commercial OfficerMay 16 '23Sale18.443817,026107,960May 17 04:16 PM
SHAROKY MELVIN MDDirectorMay 15 '23Buy19.2910,000192,90010,000May 17 04:06 PM
SHAROKY MELVIN MDDirectorMay 15 '23Buy19.2910,000192,900298,615May 17 04:06 PM
Lewis WilliamChair and CEOMay 15 '23Sale19.236,048116,303352,158May 17 04:11 PM
Adsett RogerChief Operating OfficerMay 15 '23Sale19.272,84754,862164,302May 17 04:07 PM
Flammer Martina M.D.Chief Medical OfficerMay 15 '23Sale19.282,57649,665116,624May 17 04:10 PM
Bonstein SaraChief Financial OfficerMay 15 '23Sale19.302,21042,653119,229May 17 04:09 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 15 '23Sale19.241,89736,49878,820May 17 04:14 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 15 '23Sale19.221,83035,17396,714May 17 04:13 PM
Wise John DraytonChief Commercial OfficerMay 15 '23Sale19.2959311,439108,341May 17 04:16 PM
Lewis WilliamChair and CEOMay 12 '23Option Exercise12.44233,9242,910,015233,924May 15 04:12 PM